Cogent Biosciences
COGT
#3163
Rank
โ‚ฌ4.23 B
Marketcap
24,35ย โ‚ฌ
Share price
-3.70%
Change (1 day)
-19.60%
Change (1 year)

EPS for Cogent Biosciences (COGT)

EPS in 2026 (TTM): -1,95ย โ‚ฌ

According to Cogent Biosciences's latest financial reports the company's current EPS (TTM) is -2,07ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -2,27ย โ‚ฌ a decrease over its 2024 EPS that were of -1,87ย โ‚ฌ.

EPS history for Cogent Biosciences from 2019 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,95ย โ‚ฌ-14.26%
2025-2,27ย โ‚ฌ21.32%
2024-1,87ย โ‚ฌ-14.73%
2023-2,20ย โ‚ฌ-1.63%
2022-2,23ย โ‚ฌ34.71%
2021-1,66ย โ‚ฌ-85.89%
2020-11,75ย โ‚ฌ206.9%
2019-3,83ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-0,17ย โ‚ฌ-91.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-0,87ย โ‚ฌ-58.07%๐Ÿ‡บ๐Ÿ‡ธ USA